Today, we have a special conversation with Dr. Praveen Raj, Head of Medical Affairs, who recently represented Biocon Biologics at the prestigious International Diabetes Federation (IDF) Congress. IDF is a global platform where researchers, clinicians, and industry leaders from around the world share the latest advancements in diabetes care. This year, Biocon Biologics presented six ... Continue reading In Conversation with Dr. Praveen Raj for IDF, Thailand
Biocon is an India-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of diabetes, cancer and autoimmune diseases.